Skip to main content

Truveta

By Mallory Hackett | 02:02 pm | July 15, 2021
Also: Entos works to improve drug development after closing its Series A round and Castor plans to build out its decentralized clinical trial platform with a $45 million investment.   
By Alaap B. Shah and Nivedita B. Patel | 11:54 am | March 05, 2021
Attorneys from Epstein Becker Green talk the liabilities and ethics of the new plan.